Wearable device derived electrocardiographic age and its association with atrial fibrillation

Abstract

Artificial intelligence (AI)-derived electrocardiographic (ECG) age is a promising marker of atrial fibrillation (AF) risk. We developed PROPHECG-Age Single-an AI model estimating ECG age from wearable single-lead ECGs-and examined whether the ECG-age gap (predicted minus chronological age) is associated with AF presence and burden in real-world self-monitoring context. One million 12-lead ECGs from a hospital were converted to synthetic single-lead signals via Cycle-Consistent Generative Adversarial Network and used to train a residual network-based model. Validation in two independent wearable cohorts (S-Patch [ClinicalTrials.gov: NCT05119725, registered November 2021]; Memo Patch [ClinicalTrials.gov: NCT05355948, registered May 2022]) showed mean absolute errors of 10.01 and 11.88 years, respectively. The pooled association with AF presence was significant (odds ratio 1.03 per 1-year gap), and for AF burden, each 1-year gap increase corresponded to a 0.8 percentage point rise. These findings support wearable-based AI-ECG age as a potential digital biomarker for proactive cardiovascular monitoring.

Ähnliche Arbeiten